S331119th Congress

HALT Fentanyl Act

Sponsored By: Senator Bill Cassidy

Became Law

Summary

Permanently classifies fentanyl-related substances as Schedule I and aligns their penalties with fentanyl analogues while creating faster, clearer rules for legitimate Schedule I research.

Show full summary
  • People who make, sell, or possess fentanyl-related substances face the same quantity-based penalties as fentanyl analogues. Possession or trafficking of 100 grams or more triggers a 10-year mandatory minimum.
  • Researchers and institutions get an expedited, alternative registration pathway for Schedule I studies, with electronic notices, a 45-day deadline for action on certain applications, and a 90-day allowance to continue work when a substance is newly scheduled.
  • Related research sites in the same city or county can use a single registration, new inspections can be waived in some cases, and registered researchers may perform small-scale manufacturing for research without a separate manufacturing registration. The Attorney General must publicly list substances that meet the definition and an Inspector General study of the special research procedures is due within one year.

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

Analyzed Economic Effects

2 provisions identified: 2 benefits, 0 costs, 0 mixed.

Stronger control and penalties on fentanyl-like drugs

The law makes any material with a fentanyl‑related substance a Schedule I drug, unless exempt or listed elsewhere. The Attorney General may publish a list, but a drug is controlled even if not listed if it fits the definition. Criminal and import/export penalties now also cover fentanyl‑related substances. These changes take effect on enactment.

Faster, simpler research on fentanyl substances

Registered Schedule I or II researchers can start 30 days after sending notice to the Attorney General. If not registered, the Attorney General must register you or issue an order within 45 days. If a drug is newly scheduled, you may keep working if you file a complete application within 90 days. One registration can cover multiple sites in the same city or county, and authorized staff may work under it with notice. Registered researchers can do small, research‑only manufacturing like extracts and dosage forms; growing marijuana is not allowed. DEA must post any special research process online, and rules are due in 6 months and may take effect at once.

Sponsors & CoSponsors

Sponsor

Bill Cassidy

LA • R

Cosponsors

  • Martin Heinrich

    NM • D

    Sponsored 1/30/2025

  • Chuck Grassley

    IA • R

    Sponsored 1/30/2025

  • Roger Marshall

    KS • R

    Sponsored 1/30/2025

  • Todd Young

    IN • R

    Sponsored 1/30/2025

  • Steve Daines

    MT • R

    Sponsored 1/30/2025

  • Mike Rounds

    SD • R

    Sponsored 1/30/2025

  • Shelley Capito

    WV • R

    Sponsored 1/30/2025

  • Eric Schmitt

    MO • R

    Sponsored 1/30/2025

  • John Kennedy

    LA • R

    Sponsored 1/30/2025

  • Ruben Gallego

    AZ • D

    Sponsored 1/30/2025

  • Maggie Hassan

    NH • D

    Sponsored 1/30/2025

  • Catherine Cortez Masto

    NV • D

    Sponsored 1/30/2025

  • Jeanne Shaheen

    NH • D

    Sponsored 1/30/2025

  • Angus King

    ME • I

    Sponsored 1/30/2025

  • Mark Kelly

    AZ • D

    Sponsored 1/30/2025

  • John Cornyn

    TX • R

    Sponsored 1/30/2025

  • Josh Hawley

    MO • R

    Sponsored 2/3/2025

  • Thomas Tillis

    NC • R

    Sponsored 2/3/2025

  • Lindsey Graham

    SC • R

    Sponsored 2/3/2025

  • Ted Cruz

    TX • R

    Sponsored 2/3/2025

  • Katie Britt

    AL • R

    Sponsored 2/3/2025

  • Marsha Blackburn

    TN • R

    Sponsored 2/3/2025

  • Mike Lee

    UT • R

    Sponsored 2/3/2025

  • Ashley Moody

    FL • R

    Sponsored 2/11/2025

  • David McCormick

    PA • R

    Sponsored 3/6/2025

  • Susan Collins

    ME • R

    Sponsored 3/6/2025

  • Dan Sullivan

    AK • R

    Sponsored 3/6/2025

  • James Justice

    WV • R

    Sponsored 3/6/2025

  • Pete Ricketts

    NE • R

    Sponsored 3/6/2025

  • Joni Ernst

    IA • R

    Sponsored 3/10/2025

  • Cindy Hyde-Smith

    MS • R

    Sponsored 3/11/2025

Roll Call Votes

All Roll Calls

Yes: 571 • No: 147

house vote • 6/12/2025

On Passage

Yes: 321 • No: 104

senate vote • 3/14/2025

On Passage of the Bill S. 331

Yes: 84 • No: 16

senate vote • 3/13/2025

On the Cloture Motion S. 331

Yes: 84 • No: 15

senate vote • 3/6/2025

On Cloture on the Motion to Proceed S. 331

Yes: 82 • No: 12

View on Congress.gov
Back to Legislation

Take It Personal

Get Your Personalized Policy View

Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.

Already have an account? Sign in